Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein by Small Molecules as a Potential Therapeutic Strategy for Parkinson’s Disease
Gergely Tóth(University of Cambridge), Lisa McConlogue(Gladstone Institutes), Mitali A. Tambe(Purdue University West Lafayette), Jennifer Johnston(Mill Valley Public Library), Céline Galvagnion(University of Copenhagen), Karin Regnström(Stockholm University), Shyra J. Gardai(College of San Mateo), Susan L. Roy(Purdue University West Lafayette), San-San Chiou, Wagner Zago, Nunilo Cremades(University of Cambridge), Michele Vendruscolo(University of Cambridge), Tuomas P. J. Knowles(University of Cambridge), Michael F. Jobling, Jean‐Christophe Rochet(Purdue University West Lafayette), Kari Callaway, Steven Finkbeiner(Gladstone Institutes), John Christodoulou(The University of Sydney), Carlos W. Bertoncini(University of Cambridge), Michael P. Bova, Gaia Skibinski(Michael J. Fox Foundation), Christopher M. Dobson(University of Cambridge), John P. Anderson(Sunesis (United States)), Alexander K. Buell(University of Cambridge), Dale Schenk(Athena Group (United States)), Ted Yednock(Annexon Biosciences (United States))
Cited by 155
Related Papers
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
|Nature|1995|2.5k
Aggresomes: A Cellular Response to Misfolded Proteins
|The Journal of Cell Biology|1998|2.1k
High-Level Neuronal Expression of Aβ<sub>1–42</sub>in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation
|Journal of Neuroscience|2000|1.9k